The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis

<i>NAT2</i> acetylator status was significantly associated with the likelihood of experiencing hepatotoxicity related to anti-tuberculosis drugs.

Authors

Institutions

Publication Details

Journal
Pharmacogenomics
Published
2025-12-12
DOI
https://doi.org/10.1080/14622416.2026.2624364
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis

Siddharth Sharma, Kranti Garg, Chopra, Vrunda Tavkar et al.
Pharmacogenomics
Drug-Induced Hepatotoxicity and Protection
article

The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis

Siddharth Sharma, Kranti Garg, Chopra, Vrunda Tavkar, Ankita Goyal
article en

Abstract

<i>NAT2</i> acetylator status was significantly associated with the likelihood of experiencing hepatotoxicity related to anti-tuberculosis drugs.

PharmacogenomicsVol. 26(17-18)
Thapar Institute of Engineering & Technology (IN)
Good health and well-being
Openalex Percentile: Top 26%
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis — Siddharth Sharma, Kranti Garg, et al. · Pharmacogenomics (2025) | TGRS Research Map | TGRS